Barely Significant
← all excerpts

Advanced Alzheimer's Disease Patients Show Safe, Significant, and Persistent Benefit in 6-Month Bryostatin Trial.

J Alzheimers Dis · 2023 · PMC10657679 · PMID 37742657

Europe PMCDOI
1
hedged sentence
0.0070
closest p · 0.1× alpha
0.0070
boldest claim

The sentences

highly significantp < 0.007actually significant
In this Post-hoc analysis of all points pre-specified in the Clinical Protocol, the difference in slopes between the Bryostatin-treatment group and the placebo was highly significant ( p < 0.007).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.